Nocturnal asthma

F. Blasi, M. Zanardelli, P. Castellotti, P. Tarsia

Research output: Contribution to journalArticle

Abstract

Presence of asthma symptoms during the night are a known component of the disease. It is still unclear whether night time symptoms are an expression of increased asthma severity or whether nocturnal asthma is a distinct entity. A number of mechanisms have been hypothesized to explain the phenomenon of nocturnal asthma, including exposure to dust mite allergen, late-phase allergic reactions, effects of posture and sleep stage on airway tone, gastro-esophageal reflex, impaired mucociliary clearance, airway cooling, and changes in circadian rhythms of circulating hormones. Several therapeutic options have been studied over the years. These include chronobiological use of corticosteroids, long acting β-agonists, theophylline derivatives and antileukotriene drugs. Correction of comorbidities such as gastro-esophageal reflux disease or sleep apnea may contribute to symptom control in selected cases. Further studies would be useful to better define the underlying mechanisms of nocturnal asthma and response to therapeutic measures.

Original languageEnglish
Pages (from-to)61-71
Number of pages11
JournalMinerva Pneumologica
Volume48
Issue number1
Publication statusPublished - Mar 2009

Fingerprint

Asthma
Esophageal Diseases
Mucociliary Clearance
Sleep Stages
Mites
Sleep Apnea Syndromes
Theophylline
Gastroesophageal Reflux
Circadian Rhythm
Dust
Posture
Allergens
Reflex
Comorbidity
Adrenal Cortex Hormones
Hypersensitivity
Hormones
Therapeutics
Pharmaceutical Preparations

Keywords

  • Asthma - dyspnea
  • Paroxysmal - dermatophagoides pteronyssinus- sleep apnea syndromes

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Blasi, F., Zanardelli, M., Castellotti, P., & Tarsia, P. (2009). Nocturnal asthma. Minerva Pneumologica, 48(1), 61-71.

Nocturnal asthma. / Blasi, F.; Zanardelli, M.; Castellotti, P.; Tarsia, P.

In: Minerva Pneumologica, Vol. 48, No. 1, 03.2009, p. 61-71.

Research output: Contribution to journalArticle

Blasi, F, Zanardelli, M, Castellotti, P & Tarsia, P 2009, 'Nocturnal asthma', Minerva Pneumologica, vol. 48, no. 1, pp. 61-71.
Blasi F, Zanardelli M, Castellotti P, Tarsia P. Nocturnal asthma. Minerva Pneumologica. 2009 Mar;48(1):61-71.
Blasi, F. ; Zanardelli, M. ; Castellotti, P. ; Tarsia, P. / Nocturnal asthma. In: Minerva Pneumologica. 2009 ; Vol. 48, No. 1. pp. 61-71.
@article{f0fb236a7d44442e83f59b1f7b6df23a,
title = "Nocturnal asthma",
abstract = "Presence of asthma symptoms during the night are a known component of the disease. It is still unclear whether night time symptoms are an expression of increased asthma severity or whether nocturnal asthma is a distinct entity. A number of mechanisms have been hypothesized to explain the phenomenon of nocturnal asthma, including exposure to dust mite allergen, late-phase allergic reactions, effects of posture and sleep stage on airway tone, gastro-esophageal reflex, impaired mucociliary clearance, airway cooling, and changes in circadian rhythms of circulating hormones. Several therapeutic options have been studied over the years. These include chronobiological use of corticosteroids, long acting β-agonists, theophylline derivatives and antileukotriene drugs. Correction of comorbidities such as gastro-esophageal reflux disease or sleep apnea may contribute to symptom control in selected cases. Further studies would be useful to better define the underlying mechanisms of nocturnal asthma and response to therapeutic measures.",
keywords = "Asthma - dyspnea, Paroxysmal - dermatophagoides pteronyssinus- sleep apnea syndromes",
author = "F. Blasi and M. Zanardelli and P. Castellotti and P. Tarsia",
year = "2009",
month = "3",
language = "English",
volume = "48",
pages = "61--71",
journal = "Minerva Pneumologica",
issn = "0026-4954",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "1",

}

TY - JOUR

T1 - Nocturnal asthma

AU - Blasi, F.

AU - Zanardelli, M.

AU - Castellotti, P.

AU - Tarsia, P.

PY - 2009/3

Y1 - 2009/3

N2 - Presence of asthma symptoms during the night are a known component of the disease. It is still unclear whether night time symptoms are an expression of increased asthma severity or whether nocturnal asthma is a distinct entity. A number of mechanisms have been hypothesized to explain the phenomenon of nocturnal asthma, including exposure to dust mite allergen, late-phase allergic reactions, effects of posture and sleep stage on airway tone, gastro-esophageal reflex, impaired mucociliary clearance, airway cooling, and changes in circadian rhythms of circulating hormones. Several therapeutic options have been studied over the years. These include chronobiological use of corticosteroids, long acting β-agonists, theophylline derivatives and antileukotriene drugs. Correction of comorbidities such as gastro-esophageal reflux disease or sleep apnea may contribute to symptom control in selected cases. Further studies would be useful to better define the underlying mechanisms of nocturnal asthma and response to therapeutic measures.

AB - Presence of asthma symptoms during the night are a known component of the disease. It is still unclear whether night time symptoms are an expression of increased asthma severity or whether nocturnal asthma is a distinct entity. A number of mechanisms have been hypothesized to explain the phenomenon of nocturnal asthma, including exposure to dust mite allergen, late-phase allergic reactions, effects of posture and sleep stage on airway tone, gastro-esophageal reflex, impaired mucociliary clearance, airway cooling, and changes in circadian rhythms of circulating hormones. Several therapeutic options have been studied over the years. These include chronobiological use of corticosteroids, long acting β-agonists, theophylline derivatives and antileukotriene drugs. Correction of comorbidities such as gastro-esophageal reflux disease or sleep apnea may contribute to symptom control in selected cases. Further studies would be useful to better define the underlying mechanisms of nocturnal asthma and response to therapeutic measures.

KW - Asthma - dyspnea

KW - Paroxysmal - dermatophagoides pteronyssinus- sleep apnea syndromes

UR - http://www.scopus.com/inward/record.url?scp=67649583184&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649583184&partnerID=8YFLogxK

M3 - Article

VL - 48

SP - 61

EP - 71

JO - Minerva Pneumologica

JF - Minerva Pneumologica

SN - 0026-4954

IS - 1

ER -